fromNature3 weeks agoOncogene aberrations drive medulloblastoma progression, not initiation - NatureIntratumoural heterogeneity complicates effective treatment of medulloblastoma, which is defined by diverse molecular populations, particularly in groups 3 and 4.Cancer